Hospitals Immunization Vaccines 
STAT
JUNE 6, 2023
On the other, for those who are not vulnerable or immune compromised, most facets of life have returned to normal, thanks to high levels of immunity from vaccines, boosters, and past infections. One of the last vestiges of the pandemic seems to be mask mandates in hospitals, which are now being lifted in the U.S.
STAT
NOVEMBER 24, 2022
An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 12, 2022
to receive a Covid-19 vaccine outside of a clinical trial. A study released Tuesday by the Commonwealth Fund shows that in those two years, the Covid vaccines have averted over 3 million deaths in the U.S. Without vaccines, the country would have experienced four times as many deaths, 1.5 The vaccines also saved the U.S. $1
ID Stewardship
MARCH 7, 2025
Although I have practiced in the area of infectious diseases pharmacy for quite a while now, measles has not been of much clinical relevance to me beyond MMR for routine vaccination. Vaccination is the best way to prevent measles This is an obvious one, but necessary to state right out the gate. MMR is given in 2 doses.
STAT
FEBRUARY 22, 2023
This year’s flu shot generated relatively robust levels of protection, new data show, with the vaccine’s effectiveness ranging between about 45% and 55%, depending on the age group and the metric studied, such as whether there was protection against any infection or infection that was severe enough to require hospitalization.
Express Pharma
JULY 7, 2023
Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) trial, which is led by the Universities of Glasgow, Birmingham and Oxford and a consortium of leading UK institutions.
pharmaphorum
SEPTEMBER 7, 2020
A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.
Expert insights. Personalized for you.
355 
Let's personalize your content